Previous Article | Next Article ![]()
Infection and Immunity, May 2004, p. 2915-2921, Vol. 72, No. 5
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.5.2915-2921.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Departments of Pathology and Medicine, University of California, San Diego, California 92103-8416,1 Department of Medicine, Yale University Medical School, New Haven, Connecticut 065292
Received 25 September 2003/ Returned for modification 16 November 2003/ Accepted 31 December 2003
We tested the hypothesis that cathepsins and specifically toxopain-1, a cathepsin B, play a critical role in the pathogenesis of toxoplasmosis. We found that inhibiting the expression of toxopain-1-specific mRNA and protein by >60% significantly decreased the capacity of the parasites to multiply and invade in vitro. To relate these in vitro results to the role of toxopain-1 in pathogenesis in vivo, we developed a novel chicken embryo model of congenital toxoplasmosis. Inhibiting either toxopain-1 expression or specific cysteine proteinase activity significantly reduced congenital infection of chicken embryos, as determined by histopathology and by the number of parasites quantified by real-time PCR. Our new model provides key in vivo validation for the hypothesis that toxopain-1 is a potential drug target in Toxoplasma gondii and also provides a new animal model for rapid, inexpensive screening of antiparasitic compounds.
Present address: College of Medicine, University of Arizona, Tucson, AZ 85724.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»